NCT06513403 · RECRUITING

Preliminary Research Using Artificial Intelligence Technology to Identify Differences in Facial Expressions Between Healthy People, Patients With Cognitive Decline, and Patients With Dementia

This study is testing whether artificial intelligence can detect differences in facial expressions between healthy people, those with mild cognitive decline, and those with dementia. Researchers will analyze facial cues as a potential screening tool. This is a preliminary observational study, not a treatment trial, meaning no intervention is being given and nothing is being tested for safety or effectiveness yet.

Eligibility criteria

Inclusion Criteria:
Age between 50 and 75 years.
* Experimental group:
* MCI group: CDR score of 0.5 or MMSE score between 20-25 (mild/early stage).
* Dementia group: CDR score greater than 1 or MMSE score between 10-19 (moderate/middle stage).
* Control group:
* Health group: MMSE score of 26 or above.
* Participants must be conscious and able to follow instructions.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-04-15

View full record on ClinicalTrials.gov

All APOE4 clinical trials